mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.2 |
mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.2 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.2 |
mRNA |
A-804598 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.2 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.2 |
mRNA |
BRD-A71883111 |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
AM-580 |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.2 |
mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.2 |
mRNA |
etomoxir |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.2 |